Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A6CB
|
|||
Former ID |
DNC009837
|
|||
Drug Name |
8-(biphenyl-4-yl)-N-hydroxy-8-oxooctanamide
|
|||
Synonyms |
CHEMBL95313; 8-(biphenyl-4-yl)-N-hydroxy-8-oxooctanamide; SCHEMBL1520838; BDBM50114816; 8-Biphenyl-4-yl-8-oxo-octanoic acid hydroxyamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H23NO3
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCCCCCC(=O)NO
|
|||
InChI |
1S/C20H23NO3/c22-19(10-6-1-2-7-11-20(23)21-24)18-14-12-17(13-15-18)16-8-4-3-5-9-16/h3-5,8-9,12-15,24H,1-2,6-7,10-11H2,(H,21,23)
|
|||
InChIKey |
LZZJBJLIOVNVKE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. Eur J Med Chem. 2009 Jul;44(7):2868-76. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.